Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Levicept Ltd. is a UK-based biotechnology company dedicated to the discovery and development of innovative medicines for the treatment of chronic pain. Their primary focus is on targeting the neurotrophin pathway, specifically the Nerve Growth Factor (NGF) and its receptor TrkA. Levicept's lead product candidate, LEVI-04, is a p75-Fc fusion protein designed to selectively modulate NGF activity, offering a potential new treatment paradigm for chronic pain conditions like osteoarthritis, with a differentiated mechanism of action aimed at improved safety and efficacy.
The headquarters serves as the central hub for Levicept's research and development, clinical trial management, corporate strategy, and administrative operations.
Located within the prestigious Cambridge Science Park, providing access to a vibrant ecosystem of research institutions, biotech companies, and skilled talent. Facilities are likely modern laboratory and office spaces designed for biopharmaceutical research.
As a research-driven biotech, the work culture is likely highly collaborative, innovative, and scientifically rigorous, with a strong focus on achieving breakthroughs in pain management. Employees are typically passionate about their contribution to developing new therapies.
The Cambridge location is significant due to its concentration of world-class scientific talent, research institutions (including Cambridge University), and a supportive infrastructure for biotechnology ventures, fostering innovation and collaboration.
While headquartered in the UK, Levicept Ltd.'s operational reach is global, particularly concerning its clinical development programs. The company engages with Contract Research Organizations (CROs), clinical trial sites, and regulatory authorities across multiple countries to advance its therapeutic candidates. Its business development and partnering activities also span internationally to engage with pharmaceutical companies and investors worldwide.
Milton Road, Cambridge Science Park
Cambridge
Cambridgeshire
United Kingdom
Address: N/A
N/A
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, LEVICEPT LTD' leadership includes:
LEVICEPT LTD has been backed by several prominent investors over the years, including:
No major executive hires or exits have been publicly announced for Levicept Ltd. in the last 12 months. The leadership team appears stable.
Discover the tools LEVICEPT LTD uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats for companies of Levicept's size and industry include [first_initial][last] (e.g., jsmith@levicept.com) or [first].[last] (e.g., john.smith@levicept.com).
A likely format is [first_initial][last]@levicept.com
Format
swestbrook@levicept.com
Example
75%
Success rate
BioSpace • May 9, 2023
Levicept announced positive results from its Phase I clinical trial of LEVI-04 in patients with osteoarthritis (OA) of the knee. The data, presented at the OARSI 2023 World Congress, demonstrated that LEVI-04 was well tolerated and showed encouraging signs of efficacy....more
Levicept Website (Press Release section) • October 27, 2021
Levicept Ltd. announced that the first patient has been dosed in its Phase I clinical study of LEVI-04, a p75-Fc fusion protein, in patients with osteoarthritis (OA) of the knee. The study aims to evaluate the safety, tolerability, and pharmacokinetics of LEVI-04....more
BioWorld • February 10, 2020
Levicept Ltd. secured £16 million (US$20.7 million) in a series B round, enabling the company to advance its lead program, LEVI-04, a neurotrophin modulator for chronic pain, into phase II development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including LEVICEPT LTD, are just a search away.